Andrey N. Kochetkov

Andrey N. Kochetkov

Auto-generated profile, based on publicly available information

Andrey N. Kochetkov

Volgograd State Medical University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2017 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
VRVladimir L. Rusinov
Vladimir L. Rusinov
ISIrina M. Sapozhnikova
Irina M. Sapozhnikova
ABAnastasiya M. Bliznik
Anastasiya M. Bliznik
OCOleg N. Chupakhin
Oleg N. Chupakhin
Valery N. CharushinValery N. Charushin
Valery N. Charushin
Denis BabkovDenis Babkov
Denis Babkov

8 November 2014
Verified
Book Chapter
Closed access
PDF file
PVPavel Vassiliev
Pavel Vassiliev
Alexander SpasovAlexander Spasov
Alexander Spasov
VKVadim Kosolapov
Vadim Kosolapov
AKAida Kucheryavenko
Aida Kucheryavenko
NGNataliya A. Gurova
Nataliya A. Gurova
VAVera A. Anisimova
Vera A. Anisimova

2 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
KSKonstantin Valerievich Savateev
Konstantin Valerievich Savateev
VFVictor V. Fedotov
Victor V. Fedotov
VRVladimir Rusinov
Vladimir Rusinov
SKSvetlana K. Kotovskaya
Svetlana K. Kotovskaya
Alexander SpasovAlexander Spasov
Alexander Spasov
George UskovGeorge Uskov
George Uskov
Hypercytokinemia, or cytokine storm, is one of the severe complications of viral and bacterial infections, involving the release of abnormal amounts of cytokines, resulting in a massive inflammatory response. Cytokine storm is associated with COVID-19 and sepsis high mortality rate by developing epithelial dysfunction and coagulopathy, leading to thromboembolism and multiple organ dysfunction syndrome. Anticoagulant therapy is an important tactic to prevent thrombosis in sepsis and COVID-19, but recent data show the incompatibility of modern direct oral anticoagulants and antiviral agents. It seems relevant to develop dual-action drugs with antiviral and anticoagulant properties. At the same time, it was shown that azolo[1,5-a]pyrimidines are heterocycles with a broad spectrum of antiviral activity. We have synthesized a new family of azolo[1,5-a]pyrimidines and their condensed polycyclic analogs by cyclocondensation reactions and direct CH-functionalization and studied their anticoagulant properties. Five compounds among 1,2,4-triazolo[1,5-a]pyrimidin-7-ones and 5-alkyl-1,3,4-thiadiazolo[3,2-a]purin-8-ones demonstrated higher anticoagulant activity than the reference drug, dabigatran etexilate. Antithrombin activity of most active compounds was confirmed using lipopolysaccharide (LPS)-treated blood to mimic the conditions of cytokine release syndrome. The studied compounds affected only the thrombin time value, reliably increasing it 6.5–15.2 times as compared to LPS-treated blood.

22 November 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MDMikhail S. Dzyurkevich
Mikhail S. Dzyurkevich
Denis BabkovDenis Babkov
Denis Babkov
NSNikita V. Shtyrlin
Nikita V. Shtyrlin
OMOlga Yu. Mayka
Olga Yu. Mayka
AIAlfiya Gabdulakhatovna Iksanova
Alfiya Gabdulakhatovna Iksanova
Gjumrakch AlievGjumrakch Aliev
Gjumrakch Aliev
Glucokinase is one of the promising targets for glucose-lowering agents, and the development of GK activators are now considered as one of the most promising strategies for the treatment of type 2 diabetes mellitus. In this work, a series of novel symmetric molecular constructs, in which two pyridoxine moieties are connected via sulfur-containing linkers, have been synthesized and testedin vitrofor glucokinase activation potential. The enzyme activation rates by two most active compounds at 100 μM (~150% and 130%) were comparable to that of the reference agent PF-04937319 (~154%). Both leading compounds demonstrated low cytotoxicity and excellent safety profile in acute toxicity experiment in rats after oral administration with LD50exceeding 2000 mg/kg of body weight. Binding mode of the active compounds in comparison with the reference agent was studied using molecular docking. The leading compounds represent viable preclinical candidates for the treatment of type 2 diabetes mellitus, as well as a promising starting point for the design of structural analogs with improved activity.

6 October 2021 in Molecules
Verified
Journal Article
Open access
PDF file
DMDmitriy Maltsev
Dmitriy Maltsev
Alexander SpasovAlexander Spasov
Alexander Spasov
PVPavel Vassiliev
Pavel Vassiliev
SMSkripka Maria
Skripka Maria
MMMikhail V. Miroshnikov
Mikhail V. Miroshnikov
AMAnatolii S. Morkovnik
Anatolii S. Morkovnik
A number of novel 2,3,4,5-tetrahydro[1,3]diazepino[1,2-a]benzimidazole derivatives 2 were obtained by alkylation mainly in the 1H-tautomeric form of 2,3,4,5-tetrahydro[1,3]diazepino[1,2-a]benzimidazole or its 8,9-dimethyl-substituted analog 4-chlorobenzyl bromide, 4-chloroacetic acid fluoroanilide, and 4-tert-butylphenacyl bromide in neutral medium. Compounds 3 were cyclized and synthesized earlier with 11-phenacyl-substituted diazepino[1,2-a]benzimidazoles upon heating in conc. HBr. The chemical structures of the compounds were clarified by using the 1H Nuclear Magnetic Resonance Spectroscopy (1H-NMR) technique. Anxiolytic properties were evaluated using the elevated plus maze (EPM) and open field (OF) tests. The analgesic effect of compounds was estimated with the tail flick (TF) and hot plate (HP) methods. Besides, possible the influence of the test compounds on motor activities of the animals was examined by the Grid, Wire, and Rotarod tests. Compounds 2d and 3b were the most active due to their prominent analgesic and anxiolytic potentials, respectively. The results of the performed in silico analysis showed that the high anxiolytic activity of compound 3b is explained by the combination of a pronounced interaction mainly with the benzodiazepine site of the GABAA receptor with a prominent interaction with both the specific and allosteric sites of the 5-HT2A receptor.

1 March 2018 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
AMAdrian Julian Marcus
Adrian Julian Marcus
IIIgor Iezhitsa
Igor Iezhitsa
RARenu Agarwal
Renu Agarwal
PVPavel Vassiliev
Pavel Vassiliev
Alexander SpasovAlexander Spasov
Alexander Spasov
NINafeeza Mohd Ismail
Nafeeza Mohd Ismail